# Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

> **NCT00005094** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1170 (estimated)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** celecoxib
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00005094
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 1170 (ESTIMATED)
- **Last updated:** 2013-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005094, "Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00005094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*